| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF03033360 |
| P698 | PubMed publication ID | 17197373 |
| P50 | author | Andreas Heinz | Q497907 |
| Anissa Abi-Dargham | Q4765464 | ||
| Godfrey D. Pearlson | Q21114976 | ||
| Jürgen Gallinat | Q34567777 | ||
| John Krystal | Q104111313 | ||
| P2093 | author name string | Ismene Petrakis | |
| Naomi Driesen | |||
| D Cyril D'Souza | |||
| P2860 | cites work | Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 |
| Increased baseline occupancy of D2 receptors by dopamine in schizophrenia | Q24676113 | ||
| Emotion, decision making and the orbitofrontal cortex | Q28139530 | ||
| Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions | Q28142133 | ||
| Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects | Q28146257 | ||
| Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the alpha7-nicotinic acetylcholine receptor subunit gene (CHRNA7) | Q28203593 | ||
| NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development | Q28205016 | ||
| Changes in brain activation associated with reward processing in smokers and nonsmokers. A positron emission tomography study | Q28215613 | ||
| Determinants of medication compliance in schizophrenia: empirical and clinical findings | Q28254303 | ||
| The self-medication hypothesis of substance use disorders: a reconsideration and recent applications | Q28255574 | ||
| Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study | Q28259349 | ||
| Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input | Q28301507 | ||
| Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study | Q28301780 | ||
| Addiction changes orbitofrontal gyrus function: involvement in response inhibition | Q28345708 | ||
| A neurobiological basis for substance abuse comorbidity in schizophrenia | Q28347063 | ||
| Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: evidence for monoaminergic mechanisms | Q28372016 | ||
| Predictive reward signal of dopamine neurons | Q29615397 | ||
| Anticipation of increasing monetary reward selectively recruits nucleus accumbens | Q29619743 | ||
| Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction | Q30053550 | ||
| The New York High-Risk Project. Prevalence and comorbidity of axis I disorders in offspring of schizophrenic parents at 25-year follow-up | Q30430353 | ||
| Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors. | Q30656905 | ||
| Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers | Q31874181 | ||
| Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients | Q33586360 | ||
| Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes | Q33586386 | ||
| Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? | Q33659891 | ||
| Increased dopamine transmission in schizophrenia: relationship to illness phases | Q33679807 | ||
| Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. | Q33692830 | ||
| Substance use disorders in schizophrenia: review, integration, and a proposed model | Q33865680 | ||
| Discrete coding of reward probability and uncertainty by dopamine neurons. | Q34185213 | ||
| Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden | Q34201663 | ||
| Meta-analysis of subjective sensitivity to alcohol in sons of alcoholics | Q34257093 | ||
| Low level of response to alcohol as a predictor of future alcoholism | Q34348860 | ||
| Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism | Q34355787 | ||
| Trauma, PTSD, and the course of severe mental illness: an interactive model | Q34453391 | ||
| Psychosocial aspects of substance abuse by clients with severe mental illness | Q34559116 | ||
| Substance misuse in patients with schizophrenia: epidemiology and management | Q34585142 | ||
| Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex | Q34659349 | ||
| Psychopathology risk transmission in children of parents with substance use disorders | Q35163962 | ||
| Pharmacotherapy for schizophrenia and co-occurring substance use disorders | Q35294697 | ||
| Anhedonia, self-experience in schizophrenia, and implications for treatment | Q35608274 | ||
| NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy | Q35611019 | ||
| Elevated dopa decarboxylase activity in living brain of patients with psychosis | Q35927690 | ||
| Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method | Q36050571 | ||
| First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients | Q46724711 | ||
| Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort | Q47997393 | ||
| Typical and atypical antipsychotic medications differentially affect two nondeclarative memory tasks in schizophrenic patients: a double dissociation | Q48318584 | ||
| Amygdalar recruitment during anticipation of monetary rewards: an event-related fMRI study. | Q48320991 | ||
| Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil | Q48352448 | ||
| Effects of expectations for different reward magnitudes on neuronal activity in primate striatum | Q48377236 | ||
| Operant conditioning and the orbitofrontal cortex in schizophrenic patients: unexpected evidence for intact functioning | Q48486518 | ||
| Dissociable effects of cingulate and medial frontal cortex lesions on stimulus-reward learning using a novel Pavlovian autoshaping procedure for the rat: implications for the neurobiology of emotion | Q48542635 | ||
| Brain sabotages sobriety, right on cue: Pavlov's progeny provide pictures of alcoholism | Q48556846 | ||
| Incentive-elicited brain activation in adolescents: similarities and differences from young adults. | Q48557718 | ||
| Reward value of cigarette smoking for comparably heavy smoking schizophrenic, depressed, and nonpatient smokers | Q48606772 | ||
| Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia. Olfactory identification and Wisconsin Card Sorting performance | Q48617105 | ||
| Event-related brain potentials to high-incentive stimuli in unmedicated schizophrenic patients. | Q48798057 | ||
| Presynaptic dopaminergic function in the striatum of schizophrenic patients | Q48802317 | ||
| Decreases in dopamine receptors but not in dopamine transporters in alcoholics | Q48846413 | ||
| Drug abuse in schizophrenic patients: clinical correlates and reasons for use. | Q48876065 | ||
| An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. IV. The relationship between major depressive disorder and schizophrenia. | Q50555386 | ||
| [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders] | Q51023133 | ||
| Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. | Q51098151 | ||
| Affect recognition in deficit syndrome schizophrenia. | Q51098373 | ||
| Relationship of positive and negative symptoms to cocaine abuse in schizophrenia. | Q51640917 | ||
| Effects of cocaine on hospital course in schizophrenia. | Q51676925 | ||
| Quality of life and temperament factors in schizophrenia: comparative study of patients, their siblings and controls. | Q51930145 | ||
| Early life stress and PTSD symptoms in patients with comorbid schizophrenia and substance abuse. | Q51936733 | ||
| Neurocognitive measures of prefrontal cortical dysfunction in schizophrenia. | Q51942228 | ||
| Traumatic life events and PTSD among women with substance use disorders and schizophrenia. | Q51949602 | ||
| Implications of genetic epidemiology for the prevention of substance use disorders. | Q51971297 | ||
| Conduct disorder, antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders. | Q51986298 | ||
| Gender differences in lifetime psychiatric disorders between sons and daughters of alcoholic mothers: a pilot study. | Q52027249 | ||
| Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness. | Q52081494 | ||
| Psychiatric illness in first-degree relatives of schizophrenic and surgical control patients. A family study using DSM-III criteria. | Q52082314 | ||
| A family study of schizophrenic and normal control probands: implications for the spectrum concept of schizophrenia. | Q52083347 | ||
| Discounting of delayed rewards in substance abusers: relationship to antisocial personality disorder. | Q52116201 | ||
| [Psychopathological correlates of dopaminergic dysfunction in alcoholic and schizophrenic patients]. | Q52175777 | ||
| Acute effects of drug abuse in schizophrenic patients: clinical observations and patients' self-reports | Q37920156 | ||
| A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI. | Q38429790 | ||
| Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake | Q39398493 | ||
| Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London | Q39587016 | ||
| Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study | Q39632168 | ||
| A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice | Q39680064 | ||
| A controlled family study of chronic psychoses. Schizophrenia and schizoaffective disorder | Q39709714 | ||
| Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? | Q40642477 | ||
| An 8-year follow-up of 450 sons of alcoholic and control subjects | Q40949275 | ||
| Neurobehavioural mechanisms of reward and motivation. | Q41049144 | ||
| Non-psychotic disorders in the families of process schizophrenics | Q41069249 | ||
| A two-process theory of schizophrenia: evidence from studies in post-mortem brain | Q41581748 | ||
| An independent analysis of the copenhagen sample of the Danish adoption study of schizophrenia. I. The relationship between anxiety disorder and schizophrenia | Q41638173 | ||
| Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo | Q42461970 | ||
| A family study of alcohol dependence: coaggregation of multiple disorders in relatives of alcohol-dependent probands | Q42642066 | ||
| Dissociation of reward anticipation and outcome with event-related fMRI. | Q43811290 | ||
| Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex | Q43812676 | ||
| Effects of smoking abstinence on visuospatial working memory function in schizophrenia | Q43829054 | ||
| Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol | Q43940287 | ||
| Effects of gender and family history of alcohol dependence on a behavioral task of impulsivity in healthy subjects | Q43941248 | ||
| Delayed mesolimbic system alteration in a developmental animal model of schizophrenia. | Q44185997 | ||
| Nicotine and familial vulnerability to schizophrenia: a discordant twin study | Q44214205 | ||
| The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse | Q44395755 | ||
| Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder | Q44427295 | ||
| Altered NMDA glutamate receptor antagonist response in recovering ethanol-dependent patients | Q44531004 | ||
| Schizophrenia and depression: challenging the paradigm of two separate diseases--a controlled study of schizophrenia, depression and healthy controls | Q44552111 | ||
| Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia | Q44666887 | ||
| Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohort | Q44668398 | ||
| Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action | Q44718662 | ||
| Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. | Q44793037 | ||
| Nicotine effects on brain function and functional connectivity in schizophrenia | Q44819469 | ||
| Patterns of substance abuse in schizophrenia: nature and significance | Q44929899 | ||
| Substance-abusing schizophrenics: do they self-medicate? | Q44942237 | ||
| Amphetamine modulates human incentive processing | Q44984043 | ||
| Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study | Q45083529 | ||
| Clinical heterogeneity in schizophrenia and the pattern of psychopathology in relatives: results from an epidemiologically based family study | Q45088121 | ||
| The Roscommon Family Study. IV. Affective illness, anxiety disorders, and alcoholism in relatives | Q45090793 | ||
| Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving | Q45091249 | ||
| The risk for psychiatric illness in siblings of schizophrenics: the impact of psychotic and non-psychotic affective illness and alcoholism in parents | Q45099986 | ||
| The risk for psychiatric disorders in relatives of schizophrenic and control probands: a comparison of three independent studies | Q45103654 | ||
| Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight | Q45112266 | ||
| Nicotine use in schizophrenia and disinhibition | Q45149295 | ||
| Schizophrenia patients demonstrate a distinctive pattern of decision-making impairment on the Iowa Gambling Task | Q46305836 | ||
| Adaptive coding of reward value by dopamine neurons | Q46370954 | ||
| Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders | Q46483449 | ||
| Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms | Q46531414 | ||
| Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum | Q46600038 | ||
| Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. | Q46628158 | ||
| Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers | Q46669510 | ||
| Expectations and motives for substance use in schizophrenia. | Q52212284 | ||
| Discriminative stimulus effects of ethanol: effect of training dose on the substitution of N-methyl-D-aspartate antagonists. | Q52226559 | ||
| Sociopathy, gender, and treatment outcome among outpatient substance abusers. | Q52279067 | ||
| Impaired preferences for praise in schizophrenic adolescents. | Q52290635 | ||
| Stimulus differentiation by schizophrenic and normal subjects under conditions of reward and punishment. | Q52368375 | ||
| Regional brain metabolic response to lorazepam in subjects at risk for alcoholism. | Q52508806 | ||
| Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. | Q52582625 | ||
| Motivation and performance in schizophrenia. | Q53018667 | ||
| Pharmacophilia and pharmacophobia: determinants of patients' attitudes towards antipsychotic medication. | Q53296886 | ||
| Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. | Q55056971 | ||
| Genetic differences in alcohol sensitivity and the inheritance of alcoholism risk | Q57269121 | ||
| Is Substance Abuse in Schizophrenia Related to Impulsivity, Sensation Seeking, or Anhedonia? | Q59668692 | ||
| Relationship of family history, antisocial personality disorder and personality traits in young men at risk for alcoholism | Q67581894 | ||
| Olfactory deficits in schizophrenia | Q68248146 | ||
| Deficit and nondeficit forms of schizophrenia: the concept | Q68319236 | ||
| Heroin use as an attempt to cope: clinical observations | Q69730236 | ||
| Substance abuse in schizophrenia: service utilization and costs | Q70661363 | ||
| Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia | Q70836638 | ||
| Schizophrenia subdivided by the family history of affective disorder. A comparison of symptomatology and course of illness | Q71024367 | ||
| Alcohol and drug abusers subtyped by antisocial personality and primary or secondary depressive disorder | Q72355739 | ||
| Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia | Q72668823 | ||
| Family history of alcoholism in schizophrenia | Q72815596 | ||
| Relationships between symptoms of schizophrenia and substance abuse | Q73089365 | ||
| 6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography | Q73221974 | ||
| Drug-use behavior and correlates in people with schizophrenia | Q73483168 | ||
| Glutamate receptor expression in schizophrenic brain | Q73553182 | ||
| Antisocial personality disorder, conduct disorder, and substance abuse in schizophrenia | Q73554268 | ||
| Smoking and schizophrenia: abnormal nicotinic receptor expression | Q73689160 | ||
| [Consumption patterns and motivation for use of addictive drugs in schizophrenic patients] | Q73812388 | ||
| Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies | Q73815830 | ||
| Trauma and posttraumatic stress disorder in people with schizophrenia | Q73870390 | ||
| Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia | Q73939019 | ||
| Naltrexone in the treatment of alcohol dependence | Q77347366 | ||
| Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia | Q78170727 | ||
| A twin study of individuals with both schizophrenia and alcoholism | Q93644842 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | schizophrenia | Q41112 |
| substance abuse | Q3184856 | ||
| P304 | page(s) | 235-252 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | Neurotoxicity Research | Q15764278 |
| P1476 | title | The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia | |
| P478 | volume | 10 |
| Q37901097 | A transdisciplinary perspective of chronic stress in relation to psychopathology throughout life span development. |
| Q47922273 | Altered Global Signal Topography in Schizophrenia |
| Q34048623 | Amygdala connectivity differs among chronic, early course, and individuals at risk for developing schizophrenia |
| Q36756858 | Biologic Commonalities between Mental Illness and Addiction |
| Q26781531 | Cigarette Cravings, Impulsivity, and the Brain |
| Q33870945 | Clinical and pathological features of alcohol-related brain damage |
| Q93348798 | Clinical correlates of subsyndromal depression in African American individuals with psychosis: The relationship with positive symptoms and comorbid substance dependence |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q33285122 | Comorbidity of substance abuse with other psychiatric disorders |
| Q34820251 | Continuous, but not intermittent, antipsychotic drug delivery intensifies the pursuit of reward cues |
| Q34986948 | Contribution of early environmental stress to alcoholism vulnerability |
| Q42009133 | Deep resequencing of 17 glutamate system genes identifies rare variants in DISC1 and GRIN2B affecting risk of opioid dependence |
| Q34160802 | Do reward-processing deficits in schizophrenia-spectrum disorders promote cannabis use? An investigation of physiological response to natural rewards and drug cues |
| Q92549251 | Dopamine and glutamate in schizophrenia: biology, symptoms and treatment |
| Q35121218 | GABAergic contributions to alcohol responsivity during adolescence: insights from preclinical and clinical studies |
| Q94423560 | Genetic factors for alcohol dependence and schizophrenia: common and rare variants |
| Q48607671 | Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model. |
| Q36652502 | Impaired functional connectivity of brain reward circuitry in patients with schizophrenia and cannabis use disorder: Effects of cannabis and THC. |
| Q34689535 | Impulsivity and sensation seeking in alcohol abusing patients with schizophrenia |
| Q33333124 | Incentive motivation in first-episode psychosis: a behavioural study |
| Q35583217 | Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 tesla. |
| Q47753299 | Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia |
| Q36615980 | Movement disorders: neurodevelopment and neurobehavioural expression |
| Q37059455 | Nicotine and nicotinic system in hypoglutamatergic models of schizophrenia |
| Q90828804 | Psychiatric comorbidities in alcohol use disorder |
| Q38862631 | Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats |
| Q33751954 | Reasons for illicit drug use in people with schizophrenia: Qualitative study |
| Q40110340 | Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories. |
| Q37329900 | Subjective Effects of Thiopental in Young Adults with and without a Family History of Alcoholism |
| Q60949957 | Substance Dependence Among Bipolar, Unipolar Depression and Psychotic Homeless: A Canadian National Study |
| Q38966671 | Substance use associated with short sleep duration in patients with schizophrenia or schizoaffective disorder |
| Q36826802 | Treatment consideration and manifest complexity in comorbid neuropsychiatric disorders |
Search more.